RxDoctor Payments Data

James Williams, MD

Otolaryngology · Waterbury, CTNPI 1467404657

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Intersect ENT, Inc. at 26.3% of the total. 2025 is the largest year on record at $1,361, 2.5 times the $534 reported in 2019.

$3,543in general payments, 2019–2025

Across 127 payments — averaging $27.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$933
  • GSK$569
  • Regeneron Healthcare Solutions, Inc.$412
  • Genentech USA, Inc.$294
  • Optinose US, Inc.$227
  • Sanofi$157
  • plus $951 from 16 others

What the payments were for

  • Food & beverage$3,50099%
  • Education$431%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,543 in reported general payments places this provider in the 70th percentile of 119 otolaryngology providers in Connecticut.

See all otolaryngology providers in Connecticut

Medicare billing

Part B allowed, 2024
$114,123
Medicare patients
340
Services billed
1,514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl201$6,166
Fluticasone Propionate407$4,790
Famotidine241$2,809
Levetiracetam26$2,179
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth17$1,814
Omeprazole176$1,724
Ofloxacin31$678
Cefdinir40$648
Finasteride13$518
Levocetirizine Dihydrochloride47$392
Mupirocin54$308
Montelukast Sodium25$164
CefuroximeCefuroxime Axetil11$136
Pantoprazole Sodium31$128
Esomeprazole Magnesium12$78

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Waterbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →